Which 3 Foods to Avoid for Gastrointestinal Neuroendocrine Tumors?

1 Views
administrator
administrator
07/09/23

๐ŸŒŸ Read More: https://addon.life/2021/04/12/....3-foods-to-avoid-die

No two cancers are the same and neither should your nutrition be. The most commonly asked question to dieticians and oncologists globally is โ€œWhat Should I Eat?โ€. The answer is โ€œIt Dependsโ€. It depends on the type of cancer, current treatment and supplements being taken, age, gender, BMI, lifestyle and any genetic information available. In short โ€“ the answer to โ€œWhat Should I Eatโ€ for Gastrointestinal Neuroendocrine Tumors needs to be personalized to minimize adverse interactions between nutrition (from foods/diet) and treatment, and to improve symptoms.

Foods like Barley and Blueberry should be eaten when undergoing Vincristine treatment for Gastrointestinal Neuroendocrine Tumors. On the other hand, for this cancer, Aloe Vera and Avocado should be eaten with treatment of Cyclophosphamide. On the same lines, foods like Buttermilk and Cherry should be avoided with treatment of Vincristine for this cancer. If the treatment is Cyclophosphamide, then avoid Amaranth and Beetroot.

Black Seed contains an active ingredient called Thymoquinone. Thymoquinone has CYP (drug metabolizing enzyme) interactions with Vincristine and Cyclophosphamide treatments for this cancer and hence should be avoided.

You get the point โ€“ your nutrition needs to be personalized and it needs to be re-evaluated as soon as any of the conditions change. Create and follow a nutrition plan personalized to you to minimize adverse interactions of nutrition for cancers like Gastrointestinal Neuroendocrine Tumors.

https://addon.life/onboarding/
โ˜ Create Personalized Nutrition Plan for Cancer

โœ… Facebook: https://www.facebook.com/addonForCancer/
โœ… Twitter: https://twitter.com/addonForCancer/
โœ… Instagram: https://www.instagram.com/addonForCancer/

โœ‰ Email: nutritionist@addon.life | ยฉ Copyright 2021, addon.life.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next